These results indicate that the recruitment of GKY25-treated PMNs during vascular inflammation may be impaired with weaker cell-surface attachment and higher rolling velocities possibly through the reduction of CD62L and PSGL-1 interactions with E-selectin. Here, SELL is linked to inflammatory response.